137 related articles for article (PubMed ID: 25652739)
1. Inducible T-cell receptor expression in precursor T cells for leukemia control.
Hoseini SS; Hapke M; Herbst J; Wedekind D; Baumann R; Heinz N; Schiedlmeier B; Vignali DA; van den Brink MR; Schambach A; Blazar BR; Sauer MG
Leukemia; 2015 Jul; 29(7):1530-42. PubMed ID: 25652739
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells.
Koestner W; Hapke M; Herbst J; Klein C; Welte K; Fruehauf J; Flatley A; Vignali DA; Hardtke-Wolenski M; Jaeckel E; Blazar BR; Sauer MG
Blood; 2011 Jan; 117(3):1030-41. PubMed ID: 21063028
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
[TBL] [Abstract][Full Text] [Related]
4. Focusing of the regulatory T-cell repertoire after allogeneic stem cell transplantation indicates protection from graft-
Odak I; Raha S; Schultze-Florey C; Tavil S; Ravens S; Ganser A; Förster R; Prinz I; Koenecke C
Haematologica; 2019 Dec; 104(12):e577-e580. PubMed ID: 31018979
[No Abstract] [Full Text] [Related]
5. Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.
Zeis M; Uharek L; Hartung G; Glass B; Steinmann J; Schmitz N
Hematol J; 2001; 2(2):136-44. PubMed ID: 11424006
[TBL] [Abstract][Full Text] [Related]
6. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
Jones SC; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
[TBL] [Abstract][Full Text] [Related]
7. Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia.
Parmar S; Fernandez-Vina M; de Lima M
Curr Opin Hematol; 2011 Mar; 18(2):98-104. PubMed ID: 21245756
[TBL] [Abstract][Full Text] [Related]
8. Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction.
Montagna D; Daudt L; Locatelli F; Montini E; Turin I; Lisini D; Giorgiani G; Bernardo ME; Maccario R
Cancer Res; 2006 Jul; 66(14):7310-6. PubMed ID: 16849581
[TBL] [Abstract][Full Text] [Related]
9. Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy.
Holler A; Zech M; Ghorashian S; Pike R; Hotblack A; Veliça P; Xue SA; Chakraverty R; Morris EC; Stauss HJ
Haematologica; 2016 Apr; 101(4):482-90. PubMed ID: 26802053
[TBL] [Abstract][Full Text] [Related]
10. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
11. The Contained Self-Reactive Peripheral T Cell Repertoire: Size, Diversity, and Cellular Composition.
Richards DM; Ruggiero E; Hofer AC; Sefrin JP; Schmidt M; von Kalle C; Feuerer M
J Immunol; 2015 Sep; 195(5):2067-79. PubMed ID: 26195815
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease.
Ali R; Babad J; Follenzi A; Gebe JA; Brehm MA; Nepom GT; Shultz LD; Greiner DL; DiLorenzo TP
Immunology; 2016 Aug; 148(4):339-51. PubMed ID: 27124592
[TBL] [Abstract][Full Text] [Related]
13. Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.
Hübner J; Hoseini SS; Suerth JD; Hoffmann D; Maluski M; Herbst J; Maul H; Ghosh A; Eiz-Vesper B; Yuan Q; Ott M; Heuser M; Schambach A; Sauer MG
Mol Ther; 2016 Aug; 24(7):1216-26. PubMed ID: 27138041
[TBL] [Abstract][Full Text] [Related]
14. Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation.
Imamura M; Tsutsumi Y; Miura Y; Toubai T; Tanaka J
Hematology; 2003 Feb; 8(1):19-26. PubMed ID: 12623423
[TBL] [Abstract][Full Text] [Related]
15. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
[TBL] [Abstract][Full Text] [Related]
16. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
[TBL] [Abstract][Full Text] [Related]
17. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.
Mapara MY; Kim YM; Marx J; Sykes M
Transplantation; 2003 Jul; 76(2):297-305. PubMed ID: 12883182
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Ruggeri L; Capanni M; Urbani E; Perruccio K; Shlomchik WD; Tosti A; Posati S; Rogaia D; Frassoni F; Aversa F; Martelli MF; Velardi A
Science; 2002 Mar; 295(5562):2097-100. PubMed ID: 11896281
[TBL] [Abstract][Full Text] [Related]
19. HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease.
Li J; Heinrichs J; Haarberg K; Semple K; Veerapathran A; Liu C; Anasetti C; Yu XZ
J Immunol; 2015 Jul; 195(2):717-25. PubMed ID: 26048147
[TBL] [Abstract][Full Text] [Related]
20. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
